Insider · CIK 0002014308
Philippe Menu
Files at SOPH (SOPHiA GENETICS SA). First filing Mar 20, 2026, latest Oct 7, 2026.
In brief
Philippe Menu files SEC Form 4 as officer at SOPH (SOPHiA GENETICS SA). Since Mar 20, 2026, Philippe Menu has reported 0 open-market buys worth $0 and 19 open-market sells worth $503k, the latest filed on Oct 7, 2026.
A track record needs three past buys with six months of prices behind them; Philippe Menu has 0, so none is measured yet.
The newest scored trade: sold $60k of SOPH on Oct 5, 2026, filed Oct 7, 2026, scored 17 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 19 sells worth $503k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SOPH: SOPHiA GENETICS SA
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 17Weak | SOPHiA GENETICS SA | $60k 7,394 shares | -4% | +111% from low-8% from high | |
| 16Weak | SOPHiA GENETICS SA | $39k 5,000 shares | -2% | - | |
| 16Weak | SOPHiA GENETICS SA | $43k 5,000 shares | -2% | +177% from low0% from high | |
| 16Weak | SOPHiA GENETICS SA | $38k 5,000 shares | -2% | +143% from low-2% from high | |
| 15Weak | SOPHiA GENETICS SA | $28k 5,000 shares | -2% | +88% from low-13% from high | |
| 15Weak | SOPHiA GENETICS SA | $29k 5,000 shares | -2% | +90% from low-4% from high | |
| 16Weak | SOPHiA GENETICS SA | $38k 7,393 shares | -3% | +77% from low-11% from high | |
| 15Weak | SOPHiA GENETICS SA | $28k 5,000 shares | -2% | +90% from low0% from high | |
| 10Weak | SOPHiA GENETICS SA | $25k 5,000 shares | -2% | +70% from low-12% from high | |
| 10Weak | SOPHiA GENETICS SA | $25k 5,000 shares | -2% | +75% from low-9% from high | |
| 10Weak | SOPHiA GENETICS SA | $2,800 608 shares | -0% | +64% from low-15% from high | |
| 10Weak | SOPHiA GENETICS SA | $23k 5,000 shares | -2% | +62% from low-16% from high | |
| 10Weak | SOPHiA GENETICS SA | $24k 5,000 shares | -2% | +71% from low-12% from high | |
| 10Weak | SOPHiA GENETICS SA | $3,162 608 shares | -0% | +87% from low-6% from high | |
| 10Weak | SOPHiA GENETICS SA | $7,933 1,600 shares | -1% | +78% from low-10% from high | |
| 16Weak | SOPHiA GENETICS SA | $38k 8,125 shares | -3% | +69% from low-15% from high | |
| 10Weak | SOPHiA GENETICS SA | $23k 4,731 shares | -2% | +83% from low-12% from high | |
| 10Weak | SOPHiA GENETICS SA | $25k 5,100 shares | -2% | +86% from low-10% from high | |
| 10Weak | SOPHiA GENETICS SA | $2,913 608 shares | -0% | +83% from low-12% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 5, 2026 | SOPH SOPHIA GENETICS SA | 22,394 0.03% of outstanding | $181k | Oct 5, 2026 | $215k |
| Jul 6, 2026 | SOPH SOPHIA GENETICS SA | 32,393 0.05% of outstanding | $173k | Jul 6, 2026 | $211k |
| May 19, 2026 | SOPH SOPHIA GENETICS SA | 15,608 0.02% of outstanding | $73k | May 19, 2026 | $170k |
| Apr 20, 2026 | SOPH SOPHIA GENETICS SA | 10,608 0.02% of outstanding | $56k | Apr 20, 2026 | $146k |
| Apr 6, 2026 | SOPH SOPHIA GENETICS SA | 19,556 0.03% of outstanding | $99k | Apr 6, 2026 | $81k |
| Mar 19, 2026 | SOPH SOPHIA GENETICS SA | 608 0.00% of outstanding | $2,985 | Mar 19, 2026 | $102k |
| Feb 19, 2026 | SOPH SOPHIA GENETICS SA | 5,608 0.01% of outstanding | $27k | Feb 19, 2026 | $79k |
| Jan 20, 2026 | SOPH SOPHIA GENETICS SA | 5,608 0.01% of outstanding | $31k | Jan 20, 2026 | $66k |
| Jan 6, 2026 | SOPH SOPHIA GENETICS SA | 10,006 0.01% of outstanding | $46k | Jan 6, 2026 | $19k |
| Dec 19, 2025 | SOPH SOPHIA GENETICS SA | 608 0.00% of outstanding | $2,876 | Dec 19, 2025 | $38k |
| Oct 30, 2025 | SOPH SOPHIA GENETICS SA | 1,628 0.00% of outstanding | $7,391 | Oct 30, 2025 | $28k |
| Oct 20, 2025 | SOPH SOPHIA GENETICS SA | 1,286 0.00% of outstanding | $5,543 | Oct 20, 2025 | $28k |
| Aug 19, 2025 | SOPH SOPHIA GENETICS SA | 6,833 0.01% of outstanding | $24k | Aug 19, 2025 | $20k |
| May 19, 2025 | SOPH SOPHIA GENETICS SA | 7,148 0.01% of outstanding | $21k | May 19, 2025 | $51k |
| Feb 19, 2025 | SOPH SOPHIA GENETICS SA | 18,738 0.03% of outstanding | $84k | Feb 19, 2025 | $49k |
| Jan 27, 2025 | SOPH SOPHIA GENETICS SA | 7,500 0.01% of outstanding | $32k | Jan 27, 2025 | $18k |
| Dec 19, 2024 | SOPH SOPHIA GENETICS SA | 5,544 0.01% of outstanding | $19k | Dec 19, 2024 | $17k |
| Nov 19, 2024 | SOPH SOPHiA GENETICS SA | 792 0.00% of outstanding | $2,614 | Nov 19, 2024 | $20k |
| Oct 22, 2024 | SOPH SOPHiA GENETICS SA | 792 0.00% of outstanding | $2,614 | Oct 22, 2024 | $21k |
| Oct 4, 2024 | SOPH SOPHiA GENETICS SA | 3,670 0.01% of outstanding | $12k | Oct 4, 2024 | $26k |
| Sep 19, 2024 | SOPH SOPHiA GENETICS SA | 1,583 0.00% of outstanding | $6,696 | Sep 19, 2024 | $26k |
| Aug 19, 2024 | SOPH SOPHiA GENETICS SA | 792 0.00% of outstanding | $2,645 | Aug 19, 2024 | $185k |
| Jul 19, 2024 | SOPH SOPHiA GENETICS SA | 761 0.00% of outstanding | $3,508 | Jul 19, 2024 | $186k |
| Jul 5, 2024 | SOPH SOPHiA GENETICS SA | 3,650 0.01% of outstanding | $17k | Jul 5, 2024 | $240k |
| Jun 20, 2024 | SOPH SOPHiA GENETICS SA | 761 0.00% of outstanding | $3,797 | Jun 20, 2024 | $237k |
Transactions
Every row this insider has filed, 27 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -7,394 | $8.13 | $60k | 200,993 | 8 d ago |
| Sep 14, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -5,000 | $7.88 | $39k | 208,387 | 29 d ago |
| Aug 25, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -5,000 | $8.68 | $43k | 213,387 | Aug 26, 2026 |
| Aug 12, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -5,000 | $7.52 | $38k | 218,387 | Aug 14, 2026 |
| Jul 27, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -5,000 | $5.66 | $28k | 223,387 | Jul 28, 2026 |
| Jul 13, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -5,000 | $5.70 | $29k | 228,387 | Jul 14, 2026 |
| Jul 6, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -7,393 | $5.16 | $38k | 233,387 | Jul 7, 2026 |
| Jun 25, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -5,000 | $5.50 | $28k | 240,780 | Jun 26, 2026 |
| Jun 12, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -5,000 | $4.95 | $25k | 245,780 | Jun 15, 2026 |
| May 26, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -5,000 | $4.95 | $25k | 250,780 | Jun 1, 2026 |
| May 19, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -608 | $4.61 | $2,800 | 255,780 | May 20, 2026 |
| May 12, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -5,000 | $4.67 | $23k | 256,388 | May 13, 2026 |
| Apr 27, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -5,000 | $4.82 | $24k | 261,388 | Apr 28, 2026 |
| Apr 20, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -608 | $5.20 | $3,162 | 266,388 | Apr 21, 2026 |
| Apr 14, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -1,600 | $4.96 | $7,933 | 266,996 | Apr 16, 2026 |
| Apr 10, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -3,725 | $4.68 | $17k | 272,996 | Apr 14, 2026 |
| Apr 13, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -1,000 | $4.76 | $4,764 | 271,996 | Apr 14, 2026 |
| Apr 13, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -3,400 | $4.76 | $16k | 268,596 | Apr 14, 2026 |
| Apr 8, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -2,800 | $4.84 | $14k | 278,652 | Apr 10, 2026 |
| Apr 9, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -1,931 | $4.74 | $9,152 | 276,721 | Apr 10, 2026 |
| Apr 6, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -2,700 | $4.85 | $13k | 283,852 | Apr 8, 2026 |
| Apr 2, 2026 | SOPH SOPHiA GENETICS SA | AGrant or award Ordinary Shares | +112,936 | $0.00 | $0 | 286,552 | Apr 8, 2026 |
| Apr 7, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -2,400 | $4.87 | $12k | 281,452 | Apr 8, 2026 |
| Apr 2, 2026 | SOPH SOPHiA GENETICS SA | AGrant or award Share Option (Right to Buy)derivative | +164,671 | $0.00 | $0 | 164,671 | Apr 8, 2026 |
| Apr 2, 2026 | SOPH SOPHiA GENETICS SA | AGrant or award Ordinary Shares | +112,936 | $0.00 | $0 | 112,936 | Apr 3, 2026 |
| Apr 2, 2026 | SOPH SOPHiA GENETICS SA | AGrant or award Share Option (Right to Buy)derivative | +164,671 | $0.00 | $0 | 164,671 | Apr 3, 2026 |
| Mar 19, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -608 | $4.79 | $2,913 | 173,616 | Mar 20, 2026 |
Questions about Philippe Menu
Answered from the filings on this page, as of the latest one.
Is Philippe Menu buying or selling?
In the last 12 months Philippe Menu reported 0 open-market buys worth $0 and 19 open-market sells worth $503k on SEC Form 4; the latest was sold $60k of SOPH on Oct 5, 2026. Grants, option exercises and tax withholding are not counted.
How did Philippe Menu's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Philippe Menu has 0.
Where does Philippe Menu file Form 4?
Philippe Menu has filed Form 4 at SOPH (SOPHiA GENETICS SA) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.